DE FALCO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 2.333
NA - Nord America 1.018
AS - Asia 898
SA - Sud America 121
AF - Africa 18
OC - Oceania 2
Totale 4.390
Nazione #
RU - Federazione Russa 1.713
US - Stati Uniti d'America 991
SG - Singapore 292
IE - Irlanda 193
IT - Italia 190
CN - Cina 181
HK - Hong Kong 154
VN - Vietnam 117
BR - Brasile 102
DE - Germania 76
KR - Corea 58
GB - Regno Unito 49
JP - Giappone 26
CA - Canada 24
IN - India 23
FR - Francia 21
FI - Finlandia 14
NL - Olanda 14
AT - Austria 12
GR - Grecia 12
PK - Pakistan 11
PL - Polonia 11
TR - Turchia 8
AR - Argentina 7
BE - Belgio 6
CZ - Repubblica Ceca 5
ZA - Sudafrica 5
IQ - Iraq 4
MA - Marocco 4
PY - Paraguay 4
AZ - Azerbaigian 3
EC - Ecuador 3
ID - Indonesia 3
JO - Giordania 3
SE - Svezia 3
TN - Tunisia 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CL - Cile 2
DZ - Algeria 2
ES - Italia 2
GI - Gibilterra 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
MX - Messico 2
SN - Senegal 2
AL - Albania 1
BD - Bangladesh 1
CG - Congo 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
MK - Macedonia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.390
Città #
Moscow 623
San Jose 191
Dublin 184
Hong Kong 151
Singapore 148
Santa Clara 139
Ashburn 81
Chandler 78
Seoul 58
Dallas 37
Ho Chi Minh City 37
Los Angeles 36
New York 34
Hefei 31
Beijing 30
Hanoi 30
Naples 25
Ann Arbor 24
Munich 24
Bremen 20
Princeton 19
Roxbury 19
The Dalles 19
Bengaluru 16
São Paulo 12
Cambridge 11
Warsaw 11
Jacksonville 10
Aversa 9
Montreal 9
Caserta 8
Elora 8
Medford 8
Turku 8
Tokyo 7
Amsterdam 6
Brussels 6
Falkenstein 6
Haiphong 6
Hải Dương 6
Istanbul 6
Orem 6
Vienna 6
Brno 5
Des Moines 5
Milan 5
Nuremberg 5
Wilmington 5
Frankfurt am Main 4
Groningen 4
Hillsboro 4
Johannesburg 4
Rio de Janeiro 4
San Francisco 4
Viterbo 4
Amman 3
Baku 3
Battipaglia 3
Biên Hòa 3
Chicago 3
Colle di Val d'Elsa 3
Columbus 3
Da Nang 3
Ercolano 3
Fairfield 3
Florence 3
Helsinki 3
Lappeenranta 3
Lodi 3
London 3
Manchester 3
Nanjing 3
Ninh Bình 3
Piscataway 3
Pomigliano d'Arco 3
Poplar 3
Pune 3
Rome 3
Sennori 3
Viareggio 3
Andover 2
Asunción 2
Avellino 2
Bishkek 2
Boardman 2
Brasília 2
Brooklyn 2
Campinas 2
Can Tho 2
Castellammare di Stabia 2
Castello di Brianza 2
Central 2
Chengdu 2
Chennai 2
Cinquevie 2
City of London 2
Dakar 2
Fisciano 2
Fuzhou 2
Guayaquil 2
Totale 2.371
Nome #
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 183
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 182
Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer 174
Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance 168
Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR 161
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 161
Real-world clinical outcome and safety of adjuvant therapy in stage III melanoma patients: Data from two Academic Italian Institutions 158
Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients 155
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials 154
Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer 152
Optimal treatment strategy for metastatic melanoma patients harboring BRAF-V600 mutations 151
Biomarker-guided anti-egfr rechallenge therapy in metastatic colorectal cancer 150
Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human BRAFV600E mutant colorectal cancer 150
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 146
TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities 143
Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: A case report and a review of literature 142
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 135
Light alcohol drinking and the risk of cancer development: a controversial relationship 135
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial 129
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype 124
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer 121
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia 118
Temozolomide based treatment in glioblastoma: 6 vs. 12 months 117
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 115
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941 115
Feasibility of next-generation sequencing in clinical practice: Results of a pilot study in the Department of Precision Medicine at the University of Campania ' Luigi Vanvitelli' 110
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data 110
Hypothalamic–pituitary autoimmunity in patients treated with anti-pd-1 and anti-pd-l1 antibodies 109
Treatment of cutaneous melanoma harboring smo p.Gln216arg mutation with imiquimod: An old drug with new results 107
Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression 101
How we treat locoregional melanoma 97
How we treat metastatic colorectal cancer 95
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models 94
Totale 4.462
Categoria #
all - tutte 14.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022178 7 10 5 3 33 6 10 8 4 16 28 48
2022/2023370 37 7 11 23 37 32 2 21 174 2 19 5
2023/2024187 26 6 6 9 48 39 2 3 1 5 16 26
2024/2025621 26 19 10 22 88 88 77 61 66 56 63 45
2025/20262.975 116 140 142 118 245 1.600 175 158 112 94 53 22
Totale 4.462